Arcutis Biotherapeutics, Inc. (ARQT) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • Wednesday
Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation ConferenceGlobeNewsWire • Tuesday
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026GlobeNewsWire • 10/21/26
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall ClinicalGlobeNewsWire • 10/09/26
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 10/02/26
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last?Zacks Investment Research • 09/17/26
Arcutis Biotherapeutics, Inc. (ARQT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/16/26
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare ConferenceGlobeNewsWire • 09/02/26
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and PrecigenZacks Investment Research • 08/27/26
Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/05/26
Arcutis Announces Second Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • 08/05/26
Arcutis Biotherapeutics, Inc. (ARQT) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/29/26
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 25.79%: Read This Before Placing a BetZacks Investment Research • 07/21/26
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026GlobeNewsWire • 07/15/26
Biotech Stock Arcutis Climbs Into Buy Zone As FDA Mulls Expanded Use For Key Skin TreatmentInvestors Business Daily • 07/09/26